Management of Androgenetic Alopecia in Men in 2025: A Focused Review
Canadian Dermatology Today · 2025
DOI: 10.58931/cdt.2025.61137 ↗Kurz gefasst
Fachartikel in der Zeitschrift Canadian Dermatology Today, 2025. Verfasst von Hanieh Zargham. Die Arbeit nennt 25 Literaturangaben.
Abstract (Originalsprache)
Androgenetic alopecia (AGA) affects a significant portion of the male population, with studies estimating that approximately 50% of men will experience some degree of AGA by the age of 50. This condition can lead to significant psychological distress and a reduced quality of life. Recent advancements in understanding the multifactorial etiology of AGA have led to the development of new treatment strategies. This review provides an overview of the currently available treatments for AGA in men.
Zitieren
APA
Zargham, H. (2025). Management of Androgenetic Alopecia in Men in 2025: A Focused Review. Canadian Dermatology Today. https://doi.org/10.58931/cdt.2025.61137
Vancouver
Zargham H. Management of Androgenetic Alopecia in Men in 2025: A Focused Review. Canadian Dermatology Today. 2025. doi:10.58931/cdt.2025.61137
BibTeX
@article{Zargham2025,
author = {Zargham, Hanieh},
title = {Management of Androgenetic Alopecia in Men in 2025: A Focused Review},
journal = {Canadian Dermatology Today},
year = {2025},
doi = {10.58931/cdt.2025.61137}
}
EUVIMED